Dr. Bortolussi is a former Vice President of Research of the IWK Health Centre and is Professor Emeritus of Paediatrics at Dalhousie University.  He edited “The Handbook for Clinician Scientists” which is used in many Universities in Canada and as part of the MicroResearch Curriculum. He is a fellow of Canadian Academy of Health Sciences and President of the Global Health Section of the Canadian Paediatric Society. He is presently the editor of Clinical and Investigative Medicine (CIM). 

My research is largely informed by clinical practice, where research questions regarding medication use are identified at the bedside.  My primary research interests involve appropriate medication use in older patients and reducing vaccine-preventable diseases in older populations.

Dr. Graham is an anthropologist of science, technology and medicine in the Department of Pediatrics (Infectious Diseases). She studies the cultural, technical and moral tensions in regulating one health. Interested in the moral basis of profit when disease becomes a market opportunity, she works among those who develop, regulate, commercialize, implement and use emerging pharmaceuticals and vaccines to examine their safety and efficacy.

Dr. Halperin’s applied research program focuses on vaccine program implementation and evaluation and health policy research. She has methodological expertise in mixed methods, survey research and grounded theory. Currently she is a co- investigator with the PHAC/CIHR Canadian Immunization Research Network that was established to provide Canada with a national capacity to undertake coordinated, evaluative research to inform public health policy relating to vaccine and vaccination. She is currently a Principal Investigator on a CIHR collaborative study in Nunavut and a Co-Investigator on a Public Health Agency of Canada funded program evaluation in Prince Edward Island.

Professor Herder’s research interests cluster around biomedical innovation policy, with particular focus on intellectual property law and practices connected to the commercialization of scientific research. As part of a three-year research project funded by the Canadian Institutes of Health Research, Professor Herder (Principal Investigator) and a team of interdisciplinary researchers are currently collecting empirical evidence about the inter-relationships between commercialization laws, policies, and practices and emerging health researchers. The team will use the collected empirical evidence to explore a series of normative questions about the ongoing commercialization of academic science.

Dr. Jennifer Isenor’s research areas include evaluation of the scope of practice of pharmacists, including immunizing and prescribing; assessing the use of drug and health information resources by students and clinicians; and geriatric-related research, with a focus on appropriate medication use, including deprescribing.

Dr. Langley is a pediatric infectious disease physician in the Department of Pediatrics and is cross-appointed in the Department of Community Health and Epidemiology in the Faculty of Medicine. She is based at the IWK Health Centre and the Canadian Center for Vaccinology. She conducts studies on the prevention of infectious diseases using vaccines, from phase 1 (first in humans) through to efficacy trials (phase 3) and post-marketing studies of how well vaccines work when they are used in immunization programs (phase 4). These studies are done with collaborators in public health, industry, universities, and non-governmental organizations. Dr. Langley has a particular interest in prevention of respiratory infections such as Respiratory Syncytial Virus and influenza. Her work also focuses on vaccine policy and evidence-based decision making in immunization programs.